Baltimore biotech WindMIL Therapeutics raises $32.5 million
Baltimore biotechnology firm WindMIL Therapeutics has raised a $32.5 million to support clinical trials and further development for new cancer therapies.
The Series B round was led by QiMing USA Venture Partners, the new U.S. entity of China firm QiMing. WindMIL, a cell therapy company, is previously backed by about $11 million in funding.
WindMIL was founded out of Johns Hopkins University by researchers Kimberly Noonan and Dr. Ivan Borrello. Th e clinical stage company is working to develop…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Morgan Eichensehr Source Type: news
More News: American Health | Biotechnology | Cancer | Cancer & Oncology | Cancer Therapy | China Health | Clinical Trials | Funding | Health Management | John Hopkins University | Noonan Syndrome